PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. ULTA
8. NVDA
9. GAP
10. DG

Go back to PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
(AMEX: PRVCF) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.02    P/E N/A 
Day Low $0.02    EPS $ 
Volume 30,000